NCT06241326View on ClinicalTrials.gov

Immunotherapy for Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

11,000

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Hepatocellular CarcinomaImmunotherapy
Interventions
OTHER

Immunotherapy-based Combination Therapies

immunotherapy-based combination therapies in Chinese HCC patients within the practical context of real-world conditions

Trial Locations (1)

210029

RECRUITING

Jiangsu Province Hospital, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER